TriVentures

Triventures is a global venture capital firm that invests in startups led by exceptional entrepreneurs. The fund identifies cross-industry breakthroughs that converge the best in class in health and non-health technologies such as insuretech and fintech for healthcare, e-commerce and cyber for healthcare, community driven genomics, health data marketplaces and more. The fund is strategically located in the top two geographical clusters of innovation in the world: Israel and Silicon Valley, where we review more than 700 venture deals per year. Triventures’ team is comprised of key opinion leaders in healthcare, entrepreneurship, venturing and corporate business development and has decades of accumulated industry experience and relationships.
SB

Sarah Bard

Director of Investor Relations and Communications

Michal Geva

Managing Partner and Co-Founder

Dani Goldsher

CFO

Martin Leon

Co-Founder

LL

Lihi Lubranski

Associate

Netalie Nadivi

General Partner

KB

Karin Bar Or

VP Finance

Orli Tori

Partner

Ted Tussing

Associate

43 past transactions

Vi

Seed Round in 2016
Vi delivers on-demand cardio audio workouts that are fun, effective, and adapt to you in real-time while anyone works out. Vi's mission is to democratize personal health & fitness through AI and voice

TailorMed

Venture Round in 2021
TailorMed is a health IT company that works with providers, pharmacies and manufacturers to reduce patient financial toxicity and create efficiencies across the patient treatment lifecycle. Our end-to-end platform applies algorithms and automations to make the co-pay assistance and free drug order processes seamless and leverages our deep data set to create actionable insights.

BurnAlong, Inc.

Venture Round in 2021
BurnAlong, Inc. develops an online fitness and wellness video application. Its platform allows people to work out with friends and fitness instructors across the country via video feed. It primarily serves corporate employers, municipalities, insurers and brokers, individuals, and senior citizens. BurnAlong, Inc. was formerly known as Paladym LLC. The company was incorporated in 2016 and is based in Pikesville, Maryland.

Lynx MD

Seed Round in 2019
Lynx MD Ltd develops and offers federated learning software solution that makes medical data accessible for data science and artificial intelligence (AI). It provides a cloud platform that enables hospitals and medical firms to securely access, share data in the healthcare environment, and develop artificial intelligence-based digital health applications that improves care and reduce costs. The company was founded in 2017 and is based in Tel Aviv, Israel with an additional office in California.

Genoox, Ltd.

Series B in 2018
Genoox develops and provides a cloud based big data platform for storing and managing genomic data. Its platform allows medical experts to provide genetic diagnostics and personalized treatments to their patients. Amir Trabelsi and Moshe Einhorn founded Genoox in 2014, with its headquarters in Palo Alto in California.

Genoox, Ltd.

Series B in 2021
Genoox develops and provides a cloud based big data platform for storing and managing genomic data. Its platform allows medical experts to provide genetic diagnostics and personalized treatments to their patients. Amir Trabelsi and Moshe Einhorn founded Genoox in 2014, with its headquarters in Palo Alto in California.

monogoto

Seed Round in 2021
monogoto Programmable Cellular is an Infrastructure as a Service (IaaS) enabling Enterprises, MNO and MVNO to launch many cellular use cases, from IoT Connectivity to Travel SIM, Digital Wallet and much more. In addition, monogoto's IaaS can solve specific operators needs, such as Global Roaming, IMSI Donations, HLR Proxy, Revenue Assurance and Private LTE. They are the first company to expose true Self-Service via a Console, APIs and Native Mobile App for all network components, including: SIM Card, GGSN, HLR, HSS, SMSC and MQTT.

Cardiva Medical, Inc.

Venture Round in 2012
Cardiva Medical is a medical device company that’s focused on developing and commercializing innovative vascular closure technology designed to help the body heal itself following catheterization. The company’s products include VASCADE, a vascular closure system, and Catalyst II and Catalyst III, which are designed to aid manual compression. It was founded in 2002 and headquartered in Sunnyvale, California.

Future Family, Inc.

Series B in 2022
Future Family, Inc. offers subscription plans which cover all healthcare costs and include guided care through concierge service. The company's features include, personal fertility planning, clinic matching, dedicated nurse concierge, 24/7 access to care team, digital health platform, clinic visits and procedures, labs, and medications. The company was incorporated in 2016 and is based in San Francisco, California.

Brightside Health

Series B in 2022
Brightside Health is a mental health care company that helps employees better navigate and manage their financial well-being. The company makes it simple and affordable to get expert, personalized treatment for depression and anxiety all from the comfort of home. Their mission is to help people lead healthy, vital, and productive lives by making it easy and affordable to get high-quality depression and anxiety care. Brightside was founded in 2017 and is headquartered in San Francisco, California, United States.

BioGaming

Series A in 2014
BioGaming provides an end-to-end solution for improving rehabilitation outcomes. BioGaming is win-win for both the user and the therapist. The platform incorporates home based gaming consoles and 3D sensing technologies to track patient performance, and applies sophisticated machine learning algorithms to provide detailed quantitative and qualitative reports.

Grin

Seed Round in 2021
Grin is a comprehensive digital orthodontic platform providing teeth straightening for all types of patients with a real local orthodontist. The platform also connects patients with a real orthodontist from the convenience of their smart device. They deliver responsible care from orthodontic specialists in an easily accessible and cost-effective way, Grin provides patients quality care that results in an exceptional smile together with all of the modernized convenience that they expect. Grin technology, aligned with a network of local trusted orthodontists, ensures that every patient gets the right care. The platform Grin App and Grin Scope is a patent-pending technology that offers remote monitoring for a variety of orthodontic needs. The Grin experience includes high-quality self-scans with the latest teeth straightening solutions. Practitioners and patients can now use these telemedicine tools to achieve a new, more convenient treatment journey. It was founded by Dr. Adam Schulhof, Pamela Oren-Artzi, and Alon Lipnik in 2019 and is based in Oradell, New Jersey.

EyeYon

Series C in 2021
EyeYon Medical Ltd. develops medical devices for the treatment of corneal edema. The company’s products include Hyper-CL, a hyperosmotic contact lens that extracts fluids from the corneal edema by osmosis; and DSPEK, an artificial endothelial layer for replacing an injured endothelial layer that may cause corneal edema. Its hyper osmotic contact lens is designed to improve vision and relieve pain in various clinical situations. EyeYon Medical Ltd. is based in Jerusalem, Israel.

PayGround, Inc.

Convertible Note in 2022
PayGround, Inc. designs and develops billing process and payment software solutions for the healthcare industry. The company enables healthcare providers to review patient accounts, create and send invoices, track pending and completed invoices, and see billing analytics. It also enables patients to view and pay billing records and track past and present invoices. The company serves healthcare providers and patients. PayGround, Inc. was founded in 2018 and is headquartered in Chandler, Arizona.

PayGround, Inc.

Seed Round in 2021
PayGround, Inc. designs and develops billing process and payment software solutions for the healthcare industry. The company enables healthcare providers to review patient accounts, create and send invoices, track pending and completed invoices, and see billing analytics. It also enables patients to view and pay billing records and track past and present invoices. The company serves healthcare providers and patients. PayGround, Inc. was founded in 2018 and is headquartered in Chandler, Arizona.

Day Zero Diagnostics Inc.

Venture Round in 2022
Day Zero Diagnostics (DZD) is developing a new class of diagnostic that enables a physician to switch from broad spectrum antibiotic therapy to a targeted antibiotic in 5 hours rather than the 2-5 days that it typically takes today. Unlike other molecular diagnostics that can only detect a handful of specific targets, DZD uses the entire genomic sequence and our proprietary Keynome™ algorithm to identify a comprehensive range of bacterial pathogens and their resistance characteristics within hours.
MST Medical Surgery Technologies Ltd. develops image analysis software for healthcare industry. It develops an image analysis software AutoLap, that facilitates robotic surgery, provides control of surgical procedure and an optimal field of view to surgeons; and Surgical Training Analytics (STA), a tool to captures images from actual surgical procedures performed by the surgeon in training. The company was founded in 2005 and is based in Tel Aviv, Israel with additional office in Apollo Beach, Florida.

Day Zero Diagnostics Inc.

Series A in 2019
Day Zero Diagnostics (DZD) is developing a new class of diagnostic that enables a physician to switch from broad spectrum antibiotic therapy to a targeted antibiotic in 5 hours rather than the 2-5 days that it typically takes today. Unlike other molecular diagnostics that can only detect a handful of specific targets, DZD uses the entire genomic sequence and our proprietary Keynome™ algorithm to identify a comprehensive range of bacterial pathogens and their resistance characteristics within hours.

6over6

Venture Round in 2015
6over6 offers a digital healthcare platform that enables users to perform their own eye vision test. They have reimagined all fundamental optometric tools and fitted them into smartphone, enabling a complete and accurate measurement of the refractive error of the eye, for eyeglasses and contact lens prescription, using software. GlassesOn is registered as a Class 1 Exempt Medical Device on the FDA Medical Device Listings. However, GlassesOn does not provide medical advice, and does not replace a full eye health exam.

OrthoSpace Ltd.

Venture Round in 2016
OrthoSpace develops and commercializes simple-to-implant, biodegradable balloon systems for the orthopaedic market. The company aims to create effective solutions for orthopaedics that reduce pain and increase patients’ range of motion while preserving patient bone and joint structures. The company’s first product has the CE mark and is currently marketed in Europe. InSpace™ is indicated for patients who suffer from rotator cuff injury, reducing shoulder pain and improving range of motion.

TailorMed

Series A in 2019
TailorMed is a health IT company that works with providers, pharmacies and manufacturers to reduce patient financial toxicity and create efficiencies across the patient treatment lifecycle. Our end-to-end platform applies algorithms and automations to make the co-pay assistance and free drug order processes seamless and leverages our deep data set to create actionable insights.

EyeYon

Venture Round in 2017
EyeYon Medical Ltd. develops medical devices for the treatment of corneal edema. The company’s products include Hyper-CL, a hyperosmotic contact lens that extracts fluids from the corneal edema by osmosis; and DSPEK, an artificial endothelial layer for replacing an injured endothelial layer that may cause corneal edema. Its hyper osmotic contact lens is designed to improve vision and relieve pain in various clinical situations. EyeYon Medical Ltd. is based in Jerusalem, Israel.

AngioSlide

Series D in 2013
Angioslide, founded in 2005 by Eran Hirszowicz and Amos Nahir, is a privately-held medical device company. The company has developed a unique Embolic Capture Angioplasty™ (ECA) device family that combines standard balloon angioplasty with debris removal capabilities through its suction mechanism. Physicians using the PROTEUS™ device can now capture and remove embolic particles during angioplasty procedures.

Cardiva Medical, Inc.

Venture Round in 2014
Cardiva Medical is a medical device company that’s focused on developing and commercializing innovative vascular closure technology designed to help the body heal itself following catheterization. The company’s products include VASCADE, a vascular closure system, and Catalyst II and Catalyst III, which are designed to aid manual compression. It was founded in 2002 and headquartered in Sunnyvale, California.

V-Wave

Series C in 2020
V-Wave Ltd. develops percutaneous implantable therapeutic devices for chronic heart failure patients. It offers V-Wave Shunt, a biocompatible inter-atrial unidirectional implant that is used to treat chronic heart failure patients with preserved and reduced ejection fraction (diastolic and systolic heart failure). The company was founded in 2009 and is based in Caesarea, Israel with additional offices in Israel and the United States.

Medisafe

Seed Round in 2013
MediSafe Project LTD. provides MediSafe, a cloud-synced mobile medication management solution that helps families in preventing emergencies caused by over-or under-dosing medications. It offers patient compliance and businesses solutions. The company was founded in 2012 and is based in Haifa, Israel.

TuneFork

Seed Round in 2020
TuneFork is audio personalization technology software that delivers an optimal hearing experience anywhere you go, bringing out the very best from your mobile sound system. Hearing is an individual experience. Each of us has unique hearing “earprints”. This is why no one sound system is perfect for everyone. When you listen to unbalanced audio, you will always miss something. In some cases, you may even cause damage to your hearing. TuneFork guides you through a simple test which characterizes your hearing, creating a personal Audio Profile. Because our self-test is clinically accurate, it provides the best results possible, truly the Gold Standard in Audio experience. We use the test results to tailor a precise audio filter for each and every user, creating the perfect match between your sound system and your hearing. TuneFork can be integrated into any operating or network and optimize all audio content: *Phone calls *Music *Video *Voice messages *Rings & Alerts. With the spread of IoT more and more "smart"​ devices can carry TuneFork's advanced audio technology – smart TVs, smart cars, other smart devices, but above all: smartphones. Smartphone sales stood at 1.5 billion units in 2016. Their use extends far beyond two-way communication and includes music, video viewing, social networking and gaming. Any user can benefit from using TuneFork. For some it will break barriers created by hearing impairment, while for others it will deliver an improved audio experience from their device. Comparative Advantage  A software only solution  The most accurate self-test results  Product proven by clinical tests in laboratory conditions  2 Patent pending

Colospan

Venture Round in 2017
Colospan Ltd manufactures and sells health care equipment for colorectal surgeries. The company was founded in 2010 and is based in Kfar Saba, Israel.

BioProtect

Series D in 2020
BioProtect Ltd. is an international medical device startup. It is primarily engaged in to the business of developing and commercializing biodegradable balloon spacers for the protection of normal tissue during cancer radiation therapy. The company's current focus in the growing radiotherapy spacers market, where its ProSpace balloon spacer (CE marked) has shown superior efficacy and safety in protecting the rectum during radiation therapy for prostate cancer. The company's technology platform of biodegradable implantable balloons suits a wide range of applications for unmet clinical needs. BioProtect was founded in the year 2004 and headquartered in Israel, with subsidiaries in Germany and US.

V-Wave

Series B in 2016
V-Wave Ltd. develops percutaneous implantable therapeutic devices for chronic heart failure patients. It offers V-Wave Shunt, a biocompatible inter-atrial unidirectional implant that is used to treat chronic heart failure patients with preserved and reduced ejection fraction (diastolic and systolic heart failure). The company was founded in 2009 and is based in Caesarea, Israel with additional offices in Israel and the United States.

Medisafe

Series A in 2015
MediSafe Project LTD. provides MediSafe, a cloud-synced mobile medication management solution that helps families in preventing emergencies caused by over-or under-dosing medications. It offers patient compliance and businesses solutions. The company was founded in 2012 and is based in Haifa, Israel.

Medisafe

Series B in 2017
MediSafe Project LTD. provides MediSafe, a cloud-synced mobile medication management solution that helps families in preventing emergencies caused by over-or under-dosing medications. It offers patient compliance and businesses solutions. The company was founded in 2012 and is based in Haifa, Israel.

Cala Health, Inc.

Series C in 2019
Cala Health, Inc., a bioelectronic medicine company, manufactures electromedical and electrotheraupetic devices for chronic diseases. It offers Cala Trio, a non-invasive prescription therapy for hand tremors in people with essential tremor. The company’s Cala Trio aids in the transient relief of hand tremors in the treated hand following stimulation in adults with essential tremor. In addition, it develops neurology, cardiology, and psychiatry solutions. Cala Health, Inc. was formerly known as Resido Medical, Inc. The company was founded in 2013 and is based in Burlingame, California.

Apica Cardiovascular

Venture Round in 2014
Apica Cardiovascular is a pre revenue medical device company commercializing a technology for access and closure of the heart’s apex and the peripheral vascular system. The underlying technology has applications in a number of medical procedures such as Transcatheter Heart Valves (TAVI), AAA, and LVAD implantation. The technology standardizes access and closure for large bore therapeutic devices without loss of blood via minimally invasive surgical or percutaneous access on the beating heart. The technology has progressed to the point where it has proven the initial concept in animal and cadaver models and is now moving toward initial clinical trials.
MST Medical Surgery Technologies Ltd. develops image analysis software for healthcare industry. It develops an image analysis software AutoLap, that facilitates robotic surgery, provides control of surgical procedure and an optimal field of view to surgeons; and Surgical Training Analytics (STA), a tool to captures images from actual surgical procedures performed by the surgeon in training. The company was founded in 2005 and is based in Tel Aviv, Israel with additional office in Apollo Beach, Florida.

ZingBox Studio

Series B in 2017
ZingBox Inc. develops an enterprise Internet of Things (IoT) security solution to discover and protect the connected equipment. The company offers ZingBox, a real-time IoT security solution to protect from cyber and insider threats. It offers its solution primarily for healthcare and manufacturing industries. ZingBox Inc. has a strategic partnership First Health Advisory Solutions. The company was founded in 2014 and is based in Mountain View, California. ZingBox Inc. operates as a subsidiary of Palo Alto Networks, Inc.

V-Wave

Series C in 2018
V-Wave Ltd. develops percutaneous implantable therapeutic devices for chronic heart failure patients. It offers V-Wave Shunt, a biocompatible inter-atrial unidirectional implant that is used to treat chronic heart failure patients with preserved and reduced ejection fraction (diastolic and systolic heart failure). The company was founded in 2009 and is based in Caesarea, Israel with additional offices in Israel and the United States.

OrthoSpace Ltd.

Venture Round in 2015
OrthoSpace develops and commercializes simple-to-implant, biodegradable balloon systems for the orthopaedic market. The company aims to create effective solutions for orthopaedics that reduce pain and increase patients’ range of motion while preserving patient bone and joint structures. The company’s first product has the CE mark and is currently marketed in Europe. InSpace™ is indicated for patients who suffer from rotator cuff injury, reducing shoulder pain and improving range of motion.

CathWorks

Series B in 2017
CathWorks develops medical devices for the interventional cardiology market. The company’s technology is based on processing visual information and automatic multi-layered algorithms. CathWorks’ technology is focused on improving the utilization of coronary angiography data to ratify measurement-based medicine in the cath lab. CathWorks is a privately-held Israeli company established in 2013. It is supported by a dominant strategic partner as well as leading venture capital firms in the medical devices arena.

AngioSlide

Series E in 2015
Angioslide, founded in 2005 by Eran Hirszowicz and Amos Nahir, is a privately-held medical device company. The company has developed a unique Embolic Capture Angioplasty™ (ECA) device family that combines standard balloon angioplasty with debris removal capabilities through its suction mechanism. Physicians using the PROTEUS™ device can now capture and remove embolic particles during angioplasty procedures.

Vi

Series A in 2018
Vi delivers on-demand cardio audio workouts that are fun, effective, and adapt to you in real-time while anyone works out. Vi's mission is to democratize personal health & fitness through AI and voice

Medisafe

Series C in 2021
MediSafe Project LTD. provides MediSafe, a cloud-synced mobile medication management solution that helps families in preventing emergencies caused by over-or under-dosing medications. It offers patient compliance and businesses solutions. The company was founded in 2012 and is based in Haifa, Israel.

EyeYon

Venture Round in 2015
EyeYon Medical Ltd. develops medical devices for the treatment of corneal edema. The company’s products include Hyper-CL, a hyperosmotic contact lens that extracts fluids from the corneal edema by osmosis; and DSPEK, an artificial endothelial layer for replacing an injured endothelial layer that may cause corneal edema. Its hyper osmotic contact lens is designed to improve vision and relieve pain in various clinical situations. EyeYon Medical Ltd. is based in Jerusalem, Israel.